173 related articles for article (PubMed ID: 33230714)
1. Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients.
Marquet P; Destère A; Monchaud C; Rérolle JP; Buchler M; Mazouz H; Etienne I; Thierry A; Picard N; Woillard JB; Debord J
Clin Pharmacokinet; 2021 May; 60(5):611-622. PubMed ID: 33230714
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
Woillard JB; Debord J; Monchaud C; Saint-Marcoux F; Marquet P
Clin Pharmacokinet; 2017 Dec; 56(12):1491-1498. PubMed ID: 28389935
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Brooks E; Tett SE; Isbel NM; Staatz CE
Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
[TBL] [Abstract][Full Text] [Related]
7. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.
Saint-Marcoux F; Knoop C; Debord J; Thiry P; Rousseau A; Estenne M; Marquet P
Clin Pharmacokinet; 2005; 44(12):1317-28. PubMed ID: 16372829
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
Wang XH; Shao K; An HM; Zhai XH; Zhou PJ; Chen B
Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394
[TBL] [Abstract][Full Text] [Related]
11. Bayesian optimization of tacrolimus exposure in stable kidney transplant patients.
Nguyen TD; Smith NM; Attwood K; Gundroo A; Chang S; Yonis M; Murray B; Tornatore KM
Pharmacotherapy; 2023 Oct; 43(10):1032-1042. PubMed ID: 37452631
[TBL] [Abstract][Full Text] [Related]
12. Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.
Marquet P; Saint-Marcoux F; Prémaud A; Sauvage FL; Jaqz-Aigrain E; Knoop C; Lebranchu Y; Tiberi M; Domke I; Debord J
Ther Drug Monit; 2009 Aug; 31(4):443-50. PubMed ID: 19571778
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
[TBL] [Abstract][Full Text] [Related]
14. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
Woillard JB; de Winter BC; Kamar N; Marquet P; Rostaing L; Rousseau A
Br J Clin Pharmacol; 2011 Mar; 71(3):391-402. PubMed ID: 21284698
[TBL] [Abstract][Full Text] [Related]
16. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
17. Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation.
Ponthier L; Marquet P; Moes DJAR; Rostaing L; van Hoek B; Monchaud C; Labriffe M; Woillard JB
Eur J Clin Pharmacol; 2023 Feb; 79(2):311-319. PubMed ID: 36564549
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus population pharmacokinetics in adult heart transplant patients.
Paschier A; Destere A; Monchaud C; Labriffe M; Marquet P; Woillard JB
Br J Clin Pharmacol; 2023 Dec; 89(12):3584-3595. PubMed ID: 37477064
[TBL] [Abstract][Full Text] [Related]
19. A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
Stifft F; Vandermeer F; Neef C; van Kuijk S; Christiaans MHL
Eur J Clin Pharmacol; 2020 May; 76(5):685-693. PubMed ID: 32020321
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus Bayesian Dose Adjustment in Pediatric Renal Transplant Recipients.
Marquet P; Cros F; Micallef L; Jacqz-Aigrain E; Woillard JB; Monchaud C; Saint-Marcoux F; Debord J
Ther Drug Monit; 2021 Aug; 43(4):472-480. PubMed ID: 33149055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
